E for L Aim Public Company Limited (EFORL) - Total Assets
Based on the latest financial reports, E for L Aim Public Company Limited (EFORL) holds total assets worth ฿1.29 Billion THB (≈ $40.18 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See E for L Aim Public Company Limited book value and equity for net asset value and shareholders' equity analysis.
E for L Aim Public Company Limited - Total Assets Trend (2007–2024)
This chart illustrates how E for L Aim Public Company Limited's total assets have evolved over time, based on quarterly financial data.
E for L Aim Public Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
E for L Aim Public Company Limited's total assets of ฿1.29 Billion consist of 64.2% current assets and 35.8% non-current assets.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 5.9% |
| Accounts Receivable | ฿441.75 Million | 31.4% |
| Inventory | ฿367.05 Million | 26.1% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿18.18 Million | 1.3% |
| Goodwill | ฿0.00 | 0.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how E for L Aim Public Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of E for L Aim Public Company Limited.
Key Asset Composition Facts
- Current vs. Non-Current Assets: E for L Aim Public Company Limited's current assets represent 64.2% of total assets in 2024, an increase from 12.1% in 2007.
- Cash Position: Cash and equivalents constituted 5.9% of total assets in 2024, up from 5.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 3.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 31.4% of total assets.
E for L Aim Public Company Limited Competitors by Total Assets
Key competitors of E for L Aim Public Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
E for L Aim Public Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.54 | 1.40 | 0.52 |
| Quick Ratio | 0.71 | 0.69 | 0.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿287.74 Million | ฿241.87 Million | ฿-1.05 Billion |
E for L Aim Public Company Limited - Advanced Valuation Insights
This section examines the relationship between E for L Aim Public Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.97 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 2.8% |
| Total Assets | ฿1.41 Billion |
| Market Capitalization | $16.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values E for L Aim Public Company Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: E for L Aim Public Company Limited's assets grew by 2.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for E for L Aim Public Company Limited (2007–2024)
The table below shows the annual total assets of E for L Aim Public Company Limited from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ฿1.41 Billion ≈ $43.83 Million |
+2.76% |
| 2023-12-31 | ฿1.37 Billion ≈ $42.65 Million |
-11.38% |
| 2022-12-31 | ฿1.54 Billion ≈ $48.13 Million |
-7.93% |
| 2021-12-31 | ฿1.68 Billion ≈ $52.28 Million |
+7.75% |
| 2020-12-31 | ฿1.56 Billion ≈ $48.52 Million |
-36.30% |
| 2019-12-31 | ฿2.44 Billion ≈ $76.17 Million |
-24.05% |
| 2018-12-31 | ฿3.22 Billion ≈ $100.28 Million |
-17.20% |
| 2017-12-31 | ฿3.89 Billion ≈ $121.11 Million |
-42.42% |
| 2016-12-31 | ฿6.75 Billion ≈ $210.33 Million |
-7.63% |
| 2015-12-31 | ฿7.31 Billion ≈ $227.71 Million |
-0.83% |
| 2014-12-31 | ฿7.37 Billion ≈ $229.60 Million |
+775.90% |
| 2013-12-31 | ฿840.99 Million ≈ $26.21 Million |
+1281.94% |
| 2012-12-31 | ฿60.86 Million ≈ $1.90 Million |
-62.07% |
| 2011-12-31 | ฿160.42 Million ≈ $5.00 Million |
-16.12% |
| 2010-12-31 | ฿191.26 Million ≈ $5.96 Million |
-38.92% |
| 2009-12-31 | ฿313.14 Million ≈ $9.76 Million |
-0.43% |
| 2008-12-31 | ฿314.47 Million ≈ $9.80 Million |
+31.76% |
| 2007-12-31 | ฿238.68 Million ≈ $7.44 Million |
-- |
About E for L Aim Public Company Limited
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand. The company offers clinical hematology, microscopy, chemistry, immunology, and microbiology related products. It also provides various equipment for medical devices. In addition, the company offers educational, clinical and laboratory microscopes, and scien… Read more